How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

JP Couto - Journal of clinical pathology, 2009 - jcp.bmj.com
Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …
被引用次数：45 相关文章

[引用][C] How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

J PINTO COUTO, H PRAZERES… - Journal of clinical …, 2009 - pascal-francis.inist.fr
How molecular pathology is changing and will change the therapeutics of patients with
follicular cell-derived thyroid cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

JP Couto, H Prazeres, P Castro, J Lima… - Journal of Clinical …, 2009 - search.proquest.com
Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer?

JP Couto, H Prazeres, P Castro, J Lima… - Journal of Clinical …, 2009 - jcp.bmj.com
Well-differentiated thyroid carcinomas (WDTC) comprise two well-defined histological types:
papillary and follicular thyroid carcinomas (PTC and FTC, respectively). These two types of …

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.

JP Couto, H Prazeres, P Castro, J Lima… - Journal of Clinical …, 2009 - europepmc.org
Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

JP Couto, H Prazeres, P Castro… - Journal of clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …
[PDF] psu.edu

[PDF][PDF] How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

JP Couto, H Prazeres, P Castro, J Lima, V Máximo… - J Clin Pathol, 2009 - Citeseer
Well-differentiated thyroid carcinomas comprise two welldefined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

JP Couto, H Prazeres, P Castro, J Lima… - Journal of Clinical …, 2009 - hero.epa.gov
Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …

[引用][C] How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

J PINTO COUTO, H PRAZERES… - Journal of clinical …, 2009 - BMJ Publishing Group